No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

MR Solutions Now Offers the Widest Range of Preclinical Nuclear Medicine Imaging Systems of Any Manufacturer

Editor: What To Know

  • The PET and SPECT nuclear systems can be stand-alone or clipped onto the front of any of MR Solutions' extensive range of high field, liquid helium free MRI systems or its range of cutting edge CT systems.
  • The PET scanners can also be configured to operate as an insert in the bore of all the MRI systems providing simultaneous imaging.
  • A world leader in helium free MRI systems for preclinical research laboratories MR Solutions has now developed the largest and most advanced range of preclinical nuclear medicine combination systems of any manufacturer.

A world leader in helium free MRI systems for preclinical research laboratories MR Solutions has now developed the largest and most advanced range of preclinical nuclear medicine combination systems of any manufacturer.

The PET and SPECT nuclear systems can be stand-alone or clipped onto the front of any of MR Solutions’ extensive range of high field, liquid helium free MRI systems or its range of cutting edge CT systems. The PET scanners can also be configured to operate as an insert in the bore of all the MRI systems providing simultaneous imaging. The PET and SPECT scanners range in size from 15 g for small rodents up to 12 kgs for larger animals.

The PET insert (for simultaneous scanning) or PET clip-on module (for sequential scanning) use the latest silicon photomultiplier (SiPM) technology. This provides true depth of interaction (DOI) from hardware with two pixelated layers of scintillator crystal with different matrices providing <0.8 mm resolution. All of the PET modules are fitted with MR Solution’s superior ringless detector technology.

The SPECT clip-on modules are available in different configurations with a range of transaxial views allowing optimal imaging for different sized animals.

All of MR Solution’s preclinical scanning systems are fitted with the easy to use Preclinical Scan multimodality interface. This software provides access to all the functions – MRI/CT/PET/SPECT.  Advanced functionalities are available for experienced users.

Both the CT and MRI scanners include a motorized animal bed allowing the animal to be scanned without any manual input from the operator. These precision animal beds are compatible across all of MR Solutions’ CT and MRI ranges.

MR Solutions, based in the UK, has over 30 years’ experience and in excess of 2000 installations including spectrometer sales across the world. MR Solutions holds the prestigious Queen’s Award for Enterprise awards, achieving this for Innovation in 2016 and 2019 and for International Trade in 2017. MR Solutions also has offices in the US and technical support in all the major centers.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy